Vitals… According to data compiled by the Organ Procurement and Transplant Network, 11.55% of all US liver transplants are in children under the age of 18.
2 In a 2003 study on pediatric liver disease epidemiology and impact, the authors call for esearch efforts to focus on understanding the mechanisms of pediatric disease, developing and instituting definitive therapy for pediatric heptobiliary disease, educating clinicians and the public, developing tools for early diagnosis, and initiating targeted preventative efforts.
USING MRE TO HELP CHANGE THE
COURSE OF PEDIATRIC LIVER DISEASE
Imagine your three-year-old child is
showing symptoms of jaundice, dark
urine, pale stool, easy bleeding, itching,
spider-like blood vessels visible in the skin,
and chills. After a visit to the pediatrician,
the diagnosis could potentially be life
threatening liver disease.
Consider these facts: According to the
Children’s Liver Disease Foundation,1
more children in the UK are currently
diagnosed with liver disease than
childhood leukemia. Additionally,
at least two children are diagnosed
with liver disease every day in the UK.
There are more than 100 different liver
diseases that can affect children—
some are life threatening, but all
require a lifetime of care.
Diffuse liver disease occurs in children
for a variety of reasons.
4 For example,
childhood obesity is a leading cause
of liver disease in pediatrics. Infections
such as hepatitis A, B, and C and drug
reactions may lead to the development
of liver disease in young children.